US Bancorp DE Sells 1,781 Shares of Aflac Incorporated (NYSE:AFL)

US Bancorp DE lowered its holdings in shares of Aflac Incorporated (NYSE:AFL) by 0.9% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 203,590 shares of the financial services provider’s stock after selling 1,781 shares during the period. US Bancorp DE’s holdings in Aflac were worth $22,761,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the business. Strategic Financial Concepts LLC increased its holdings in shares of Aflac by 7,001.0% during the 2nd quarter. Strategic Financial Concepts LLC now owns 667,706 shares of the financial services provider’s stock worth $596,000 after acquiring an additional 658,303 shares during the last quarter. International Assets Investment Management LLC increased its holdings in shares of Aflac by 10,878.5% in the third quarter. International Assets Investment Management LLC now owns 559,903 shares of the financial services provider’s stock valued at $62,597,000 after purchasing an additional 554,803 shares during the last quarter. Truist Financial Corp raised its position in shares of Aflac by 26.6% in the second quarter. Truist Financial Corp now owns 1,929,662 shares of the financial services provider’s stock valued at $172,338,000 after purchasing an additional 405,847 shares during the period. Swedbank AB bought a new position in shares of Aflac in the first quarter valued at about $27,588,000. Finally, Dimensional Fund Advisors LP lifted its stake in shares of Aflac by 6.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,807,079 shares of the financial services provider’s stock worth $429,319,000 after buying an additional 285,576 shares during the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.

Aflac Trading Down 0.1 %

Shares of AFL stock opened at $104.71 on Friday. Aflac Incorporated has a fifty-two week low of $75.07 and a fifty-two week high of $115.50. The stock’s fifty day moving average price is $110.52 and its two-hundred day moving average price is $97.68. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.10 and a current ratio of 0.10. The company has a market cap of $58.64 billion, a PE ratio of 15.77, a P/E/G ratio of 2.24 and a beta of 0.95.

Aflac (NYSE:AFL) last released its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.70 by $0.46. The business had revenue of $2.95 billion for the quarter, compared to analyst estimates of $4.30 billion. Aflac had a return on equity of 16.51% and a net margin of 22.02%. Aflac’s revenue was down 40.4% compared to the same quarter last year. During the same period last year, the firm posted $1.84 earnings per share. Equities analysts predict that Aflac Incorporated will post 6.83 EPS for the current fiscal year.

Aflac Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Wednesday, November 20th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.91%. The ex-dividend date of this dividend is Wednesday, November 20th. Aflac’s payout ratio is 30.12%.

Wall Street Analyst Weigh In

A number of brokerages recently commented on AFL. Evercore ISI upped their price target on shares of Aflac from $84.00 to $90.00 and gave the company an “underperform” rating in a research note on Thursday, September 26th. Citigroup increased their target price on Aflac from $84.00 to $93.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 23rd. Piper Sandler lifted their price target on Aflac from $114.00 to $122.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. Morgan Stanley upped their price objective on Aflac from $91.00 to $98.00 and gave the company an “equal weight” rating in a report on Monday, August 19th. Finally, TD Cowen began coverage on Aflac in a report on Wednesday, October 9th. They set a “hold” rating and a $102.00 target price for the company. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $97.87.

Insider Buying and Selling at Aflac

In other news, Director Thomas J. Kenny sold 2,000 shares of the stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total value of $197,880.00. Following the completion of the transaction, the director now directly owns 18,158 shares in the company, valued at approximately $1,796,552.52. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.90% of the company’s stock.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.